Literature DB >> 12644917

Shigatoxin-1 binding and receptor expression in human kidneys do not change with age.

Zuhal Ergonul1, Frederic Clayton, Agnes B Fogo, Donald E Kohan.   

Abstract

Postdiarrheal hemolytic-uremic syndrome (D+HUS) occurs predominantly in young children. The rarity of D+HUS in adults has been ascribed to aging-associated loss of glomerular globotriaosylceramide (Gb3) expression, the major cognate receptor for shigatoxin. This belief, however, is based on relatively little data. The current study was undertaken to examine renal shigatoxin-1 (Stx-1) binding and Gb3 expression by human kidneys from varying aged subjects. Immunofluorescent staining and thin layer chromatography of neutral lipid extracts were performed. Abundant Stx-1 binding to both glomeruli and tubules was observed in frozen renal sections from all subjects of all ages (6 months to 85 years). The pattern of Stx-1 binding was identical between adults and children, with glomerular endothelial cells and cortical tubules being strongly labeled. Stx-1 binding affinity was similar between pediatric and adult kidneys. Antibodies to Gb3 showed a similar pattern and degree of staining regardless of donor age. In addition, Gb3 levels in glomeruli and tubules isolated from fresh kidney tissue were comparable between different aged donors. These data demonstrate that intrinsic renal binding of Stx-1 does not vary with age. It is suggested that factors other than basal renal Gb3 expression account for the age-related incidence of acute renal failure in D+HUS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644917     DOI: 10.1007/s00467-002-1025-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  19 in total

1.  Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome.

Authors:  D Maroeska W M Te Loo; Victor W M VAN Hinsbergh; Lambertus P W J VAN DEN Heuvel; Leo A H Monnens
Journal:  J Am Soc Nephrol       Date:  2001-04       Impact factor: 10.121

2.  Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic.

Authors:  S Arab; C A Lingwood
Journal:  J Cell Physiol       Date:  1998-12       Impact factor: 6.384

3.  The hemolytic-uremic syndrome and Escherichia coli O157:H7 infection.

Authors:  W L Robson; A K Leung
Journal:  Ann Intern Med       Date:  1993-08-01       Impact factor: 25.391

Review 4.  Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.

Authors:  P Ruggenenti; M Noris; G Remuzzi
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

5.  Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases.

Authors:  G H Foster; C S Armstrong; R Sakiri; V L Tesh
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.

Authors:  C B Louise; T G Obrig
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

7.  Verotoxin-binding in human renal sections.

Authors:  C A Lingwood
Journal:  Nephron       Date:  1994       Impact factor: 2.847

8.  Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.

Authors:  N A Strockbine; L R Marques; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells.

Authors:  A K Hughes; P K Stricklett; D E Kohan
Journal:  Kidney Int       Date:  1998-08       Impact factor: 10.612

10.  Shiga toxin 1 elicits diverse biologic responses in mesangial cells.

Authors:  M Simon; T G Cleary; J D Hernandez; H E Abboud
Journal:  Kidney Int       Date:  1998-10       Impact factor: 10.612

View more
  21 in total

1.  Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells.

Authors:  Irina Maluykova; Oksana Gutsal; Marina Laiko; Anne Kane; Mark Donowitz; Olga Kovbasnjuk
Journal:  Biochim Biophys Acta       Date:  2008-02-20

Review 2.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections.

Authors:  Carmen Valbuena; Dina Leitão; Fátima Carneiro; João Paulo Oliveira
Journal:  Virchows Arch       Date:  2011-12-29       Impact factor: 4.064

4.  Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling.

Authors:  Marina Morigi; Simona Buelli; Cristina Zanchi; Lorena Longaretti; Daniela Macconi; Ariela Benigni; Daniela Moioli; Giuseppe Remuzzi; Carla Zoja
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 5.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.

Authors:  Carla Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2010-04-28       Impact factor: 3.714

Review 6.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

7.  Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora.

Authors:  Krystle L Mohawk; Angela R Melton-Celsa; Tonia Zangari; Erica E Carroll; Alison D O'Brien
Journal:  Microb Pathog       Date:  2010-01-22       Impact factor: 3.738

8.  Immunohistologic techniques for detecting the glycolipid Gb(3) in the mouse kidney and nervous system.

Authors:  Glynis L Kolling; Fumiko Obata; Lisa K Gross; Tom G Obrig
Journal:  Histochem Cell Biol       Date:  2008-03-26       Impact factor: 4.304

9.  Shiga toxin 2 targets the murine renal collecting duct epithelium.

Authors:  Mitchell A Psotka; Fumiko Obata; Glynis L Kolling; Lisa K Gross; Moin A Saleem; Simon C Satchell; Peter W Mathieson; Tom G Obrig
Journal:  Infect Immun       Date:  2009-01-05       Impact factor: 3.441

10.  Macropinocytosis in Shiga toxin 1 uptake by human intestinal epithelial cells and transcellular transcytosis.

Authors:  Irina Malyukova; Karen F Murray; Chengru Zhu; Edgar Boedeker; Anne Kane; Kathleen Patterson; Jeffrey R Peterson; Mark Donowitz; Olga Kovbasnjuk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-30       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.